| For: | Ye L, Yan K, Tian Z, Xiao ZH, Xie RY, Xie ZY, Tao L. Helicobacter pylori infection is linked to metabolic dysfunction and associated steatotic liver disease: A large cross-sectional study. World J Gastroenterol 2025; 31(13): 102563 [PMID: 40248064 DOI: 10.3748/wjg.v31.i13.102563] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i13/102563.htm |
| Number | Citing Articles |
| 1 |
Edward V Kasparov, Aleksander A Sinyakov, Olga V Smirnova. <i>Helicobacter pylori</i> infection as a risk factor in the development of metabolic dysfunction-associated steatotic liver disease. World Journal of Hepatology 2025; 17(10): 110833 doi: 10.4254/wjh.v17.i10.110833
|
| 2 |
Yan'an Zhou, Yuchen Zhu, Shuai Li, Zekun He, Yao Zhang, Zonglei Wang, Cong He, Hongtao Zhu, Nianshuang Li, Junming Li, Junyun Feng, Xiao Fei, Xingxing He, Huan Wang, Da Gan, Xia Huang, Nonghua Lv, Yuhui Wang, Wenhua He, Xidong Wu, Yin Zhu, Jianping Liu. A Bidirectional Association Between Helicobacter pylori Infection and Hyperlipidemia: Clinical Evidence and Mechanistic Insights. Helicobacter 2026; 31(3) doi: 10.1111/hel.70135
|
| 3 |
Joseph M Pappachan, Cornelius J Fernandez, Sanja Medenica. <i>Helicobacter pylori</i> and diabetic complications: Stronger evidence for the interlink. World Journal of Diabetes 2026; 17(6): 119178 doi: 10.4239/wjd.119178
|
| 4 |
Elena V. Onuchina. Non-alcoholic fatty liver disease and <i>Helicobacter pylori</i> infection: problems and solutions. A review. Consilium Medicum 2026; 28(5) doi: 10.26442/20751753.2026.5.203707
|
| 5 |
Meenakshi Kandpal, Tarun Prakash Verma, Siddharth Singh, Hamendra Parmar, Hem Chandra Jha. Metabolomic and lipidomic signatures of Helicobacter pylori infection: Unveiling biochemical pathways associated with neurodegeneration. iMetaOmics 2026; 3(2) doi: 10.1002/imo2.70088
|
| 6 |
Zhimao Cai, Hualang Cai, Dan Zhou, Zhenzhou Li, Jiashuang Lin, Ye Ye, Sixia Chen, Rourou Li, Mengjia Chen, Yuan Dai, Hui Peng, Weifeng Chen. Non-linear association between cardiometabolic index and helicobacter pylori infection: a cross-sectional study. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-04171-9
|
| 7 |
Jun Huang, Yaohong Xie, Jian Huang, Bingyun Lu, Ye Chen. Accuracy and Agreement of a 45 mg Versus a 75 mg 13C-Urea Breath Test for the Diagnosis of Helicobacter pylori Infection in Adults: A Randomized Crossover Trial. Diagnostics 2026; 16(10) doi: 10.3390/diagnostics16101567
|
| 8 |
Noube Julie Raissa, Shuo-Yi Yao, Fen Wang. Relationship between <i>Helicobacter pylori</i> infection and the development of metabolic dysfunction and associated steatotic liver disease. World Journal of Gastroenterology 2025; 31(33): 110176 doi: 10.3748/wjg.v31.i33.110176
|
| 9 |
Han Chen, Yan Wang, Yuting Shao, Wei Su, Shuo Li, Yun Liu, Xiaoying Zhou. Multi‐Omics Analysis Revealed Characterization of Gastric Microbiome and Metabolome in Helicobacter pylori‐Induced Progression of MASLD. Helicobacter 2025; 30(5) doi: 10.1111/hel.70069
|
| 10 |
Yue Zhang, Ruifeng Duan, Yuzhong Zhang, Lijuan Wei. Association between Helicobacter pylori infection and MASLD: a cross-sectional study with interpretable machine learning for MASLD risk prediction. Frontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1730461
|
| 11 |
Chonghe Xu, Shuping Lu, Shulei Zhang, Miaosu Chang, Shuo Zhang, Wei Xu, Mei Zhu. Systemic serological signatures and novel biomarker CST4 link CagA-positive Helicobacter pylori to broad systemic alterations. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1826407
|